12 Health Care Stocks Moving In Thursday's Pre-Market Session

Gainers

  • Neoleukin Therapeutics NLTX stock moved upwards by 32.4% to $0.7 during Thursday's pre-market session. The company's market cap stands at $29.9 million.
  • Biophytis BPTS shares increased by 28.02% to $0.64. The market value of their outstanding shares is at $13.0 million.
  • First Wave BioPharma FWBI shares increased by 26.75% to $4.5. The company's market cap stands at $4.4 million.
  • Macrogenics MGNX shares moved upwards by 18.18% to $6.5. The company's market cap stands at $399.5 million.
  • Avenue Therapeutics ATXI stock rose 16.34% to $1.21. The market value of their outstanding shares is at $6.6 million.
  • Ampio Pharmaceuticals AMPE stock moved upwards by 11.93% to $0.34. The market value of their outstanding shares is at $5.0 million.

Losers

  • OptimizeRx OPRX stock decreased by 18.4% to $13.25 during Thursday's pre-market session. The company's market cap stands at $227.2 million. The company's, Q4 earnings came out yesterday.
  • Landos Biopharma LABP shares decreased by 13.14% to $0.33. The market value of their outstanding shares is at $13.2 million.
  • Akebia Therapeutics AKBA shares decreased by 11.66% to $0.91. The company's market cap stands at $167.6 million. As per the press release, Q4 earnings came out today.
  • Fulcrum Therapeutics FULC shares decreased by 10.39% to $5.61. The company's market cap stands at $345.9 million. As per the press release, Q4 earnings came out today.
  • Ontrak OTRKP stock decreased by 9.2% to $0.79.
  • Novo Integrated Sciences NVOS shares fell 8.08% to $0.18. The company's market cap stands at $24.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!